chap 3 Flashcards
An NP would prescribe the liquid form of ibuprofen for a 6-year-old child because:
- Drugs given in liquid form are less irritating to the stomach.
- A 6-year-old child may have problems swallowing a pill.
- Liquid forms of medication eliminate the concern for first-pass effect.
- Liquid ibuprofen does not have to be dosed as often as the tablet form.
- A 6-year-old child may have problems swallowing a pill.
In deciding which of multiple drugs used to use to treat a condition, the NP chooses Drug A because it:
- Has serious side effects and it is not being used for a life-threatening condition
- Will be taken twice daily and will be taken at home
- Is expensive, but covered by health insurance
- None of these are important in choosing a drug
- Will be taken twice daily and will be taken at home
A client asks the NP about the differences in drug effects between men and women. What is known about the differences between the pharmacokinetics of men and women?
- Body temperature varies between men and women.
- Muscle mass is greater in women.
- Percentage of fat differs between genders.
- Proven subjective factors exist between the genders.
- Percentage of fat differs between genders.
The first step in the prescribing process according to the World Health Organization is:
- Choosing the treatment
- Educating the patient about the medication
- Diagnosing the patient’s problem
- Starting the treatment
- Diagnosing the patient’s problem
Treatment goals in prescribing should:
- Always be curative
- Be patient-centered
- Be convenient for the provider
- Focus on the cost of therapy
- Be patient-centered
The therapeutic goals when prescribing include(s):
- Curative
- Palliative
- Preventive
- All of the above
- All of the above
When determining drug treatment the NP prescriber should:
- Always use evidence-based guidelines
- Individualize the drug choice for the specific patient
- Rely on his or her experience when prescribing for complex patients
- Use the newest drug on the market for the condition being treated
- Individualize the drug choice for the specific patient
Patient education regarding prescribed medication includes:
- Instructions written at the high school reading level
- Discussion of expected adverse drug reactions
- How to store leftover medication such as antibiotics
- Verbal instructions always in English
- Discussion of expected adverse drug reactions
Passive monitoring of drug effectiveness includes:
- Therapeutic drug levels
- Adding or subtracting medications from the treatment regimen
- Ongoing provider visits
- Instructing the patient to report if the drug is not effective
- Instructing the patient to report if the drug is not effective
Pharmacokinetic factors that affect prescribing include:
- Therapeutic index
- Minimum effective concentration
- Bioavailability
- Ease of titration
- Bioavailibity
Pharmaceutical promotion may affect prescribing. To address the impact of pharmaceutical promotion, the following recommendations have been made by the Institute of Medicine:
- Conflicts of interest and financial relationships should be disclosed by those providing education.
- Providers should ban all pharmaceutical representatives from their office setting.
- Drug samples should be used for patients who have the insurance to pay for them, to ensure the patient can afford the medication.
- Providers should only accept low-value gifts, such as pens and pads of paper, from the pharmaceutical representative.
- Conflicts of interest and financial relationships should be disclosed by those providing education.
Under new U.S. Food and Drug Administration labeling, Pregnancy Categories will be:
- Strengthened with a new coding such as C+ or C- to discern when a drug is more or less toxic to the fetus
- Changed to incorporate a pregnancy risk summary and clinical considerations on the drug label
- Eliminated, and replaced with a link to the National Library of Medicine TOXNET Web site for in-depth information regarding pregnancy concerns
- Clarified to include information such as safe dosages in each trimester of pregnancy
- Changed to incorporate a pregnancy risk summary and clinical considerations on the drug label